tetano
Editor, Senior Moderator
PLoS Biol
. 2022 Mar 31;20(3):e3001592.
doi: 10.1371/journal.pbio.3001592. Online ahead of print.
Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection
Kyung Ku Jang[SUP] 1 [/SUP], Maria E Kaczmarek[SUP] 2 [/SUP], Simone Dallari[SUP] 1 [/SUP], Ying-Han Chen[SUP] 1 [/SUP], Takuya Tada[SUP] 2 [/SUP], Jordan Axelrad[SUP] 3 [/SUP], Nathaniel R Landau[SUP] 2 [/SUP], Kenneth A Stapleford[SUP] 2 [/SUP], Ken Cadwell[SUP] 1 2 3 [/SUP]
Affiliations
Abstract
Gastrointestinal effects associated with Coronavirus Disease 2019 (COVID-19) are highly variable for reasons that are not understood. In this study, we used intestinal organoid-derived cultures differentiated from primary human specimens as a model to examine interindividual variability. Infection of intestinal organoids derived from different donors with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) resulted in orders of magnitude differences in virus replication in small intestinal and colonic organoid-derived monolayers. Susceptibility to infection correlated with angiotensin I converting enzyme 2 (ACE2) expression level and was independent of donor demographic or clinical features. ACE2 transcript levels in cell culture matched the amount of ACE2 in primary tissue, indicating that this feature of the intestinal epithelium is retained in the organoids. Longitudinal transcriptomics of organoid-derived monolayers identified a delayed yet robust interferon signature, the magnitude of which corresponded to the degree of SARS-CoV-2 infection. Interestingly, virus with the Omicron variant spike (S) protein infected the organoids with the highest infectivity, suggesting increased tropism of the virus for intestinal tissue. These results suggest that heterogeneity in SARS-CoV-2 replication in intestinal tissues results from differences in ACE2 levels, which may underlie variable patient outcomes.
. 2022 Mar 31;20(3):e3001592.
doi: 10.1371/journal.pbio.3001592. Online ahead of print.
Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection
Kyung Ku Jang[SUP] 1 [/SUP], Maria E Kaczmarek[SUP] 2 [/SUP], Simone Dallari[SUP] 1 [/SUP], Ying-Han Chen[SUP] 1 [/SUP], Takuya Tada[SUP] 2 [/SUP], Jordan Axelrad[SUP] 3 [/SUP], Nathaniel R Landau[SUP] 2 [/SUP], Kenneth A Stapleford[SUP] 2 [/SUP], Ken Cadwell[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 35358182
- DOI: 10.1371/journal.pbio.3001592
Abstract
Gastrointestinal effects associated with Coronavirus Disease 2019 (COVID-19) are highly variable for reasons that are not understood. In this study, we used intestinal organoid-derived cultures differentiated from primary human specimens as a model to examine interindividual variability. Infection of intestinal organoids derived from different donors with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) resulted in orders of magnitude differences in virus replication in small intestinal and colonic organoid-derived monolayers. Susceptibility to infection correlated with angiotensin I converting enzyme 2 (ACE2) expression level and was independent of donor demographic or clinical features. ACE2 transcript levels in cell culture matched the amount of ACE2 in primary tissue, indicating that this feature of the intestinal epithelium is retained in the organoids. Longitudinal transcriptomics of organoid-derived monolayers identified a delayed yet robust interferon signature, the magnitude of which corresponded to the degree of SARS-CoV-2 infection. Interestingly, virus with the Omicron variant spike (S) protein infected the organoids with the highest infectivity, suggesting increased tropism of the virus for intestinal tissue. These results suggest that heterogeneity in SARS-CoV-2 replication in intestinal tissues results from differences in ACE2 levels, which may underlie variable patient outcomes.